Close
Nordic 9Nordic 9

EpilepsyGTx (private company)

United Kingdom epilepsygtx.com
See something wrong or missing? Let us know
Offices:Cambridge
Industry:BiotechHealth servicesPharma
Business model:B2B

EpilepsyGTx is a British late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 10M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to EpilepsyGTx

Name Criteria
France AbolerIS Pharma
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark Octarine Bio
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom ReViral
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 10M+ USD
Top